Literature DB >> 4883503

Current therapy of rheumatoid arthritis.

E J Kamin, C V Multz.   

Abstract

The well informed and well motivated patient with rheumatoid arthritis today has an excellent chance of avoiding serious disability and deformity. No available pharmacologic agent can permanently alter the course of the disease, and no pharmacologic agent can preclude the need for a balanced program emphasizing moderation, rest and constant attention to physical therapy. Early synovectomy is enjoying increasing popularity although the long-term benefits have yet to be established. The several drugs now undergoing trial hold little promise of materially altering the management of rheumatoid arthritis in the near future. The skills of physician, surgeon, and physiatrist must be brought to bear to provide optimal care.

Entities:  

Mesh:

Year:  1969        PMID: 4883503      PMCID: PMC1503423     

Source DB:  PubMed          Journal:  Calif Med        ISSN: 0008-1264


  28 in total

1.  Fibrinolytic treatment of rheumatoid arthritis with phenformin plus ethyloestrenol.

Authors:  G R Fearnley; R Chakrabarti
Journal:  Lancet       Date:  1966-10-08       Impact factor: 79.321

2.  Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis.

Authors:  M F Kahn; M Bedoiseau; S de Sèze
Journal:  Proc R Soc Med       Date:  1967-02

3.  Salicylates and bleeding: the aspirin tolerance test.

Authors:  A J Quick
Journal:  Am J Med Sci       Date:  1966-09       Impact factor: 2.378

4.  Posterior (dorsal) synovectomy for rheumatoid involvement of the hand and wrist. A follow-up study of sixty-six procedures.

Authors:  I Kessler; K Vainio
Journal:  J Bone Joint Surg Am       Date:  1966-09       Impact factor: 5.284

5.  Relative efficacy of indomethacin and acetylsalicylic acid in rheumatoid arthritis.

Authors:  R S Pinals; S Frank
Journal:  N Engl J Med       Date:  1967-03-02       Impact factor: 91.245

6.  Fibrin promotion and lysis in arthritic joints.

Authors:  M I Barnhart; J M Riddle; G B Bluhm; C Quintana
Journal:  Ann Rheum Dis       Date:  1967-05       Impact factor: 19.103

7.  Delayed onset of chloroquine retinopathy.

Authors:  R P Burns
Journal:  N Engl J Med       Date:  1966-09-29       Impact factor: 91.245

8.  Potentiation of anticoagulant effect of warfarin by phenylbutazone.

Authors:  P M Aggeler; R A O'Reilly; L Leong; P E Kowitz
Journal:  N Engl J Med       Date:  1967-03-02       Impact factor: 91.245

9.  Thymectomy in acute systemic lupus erythematosus and rheumatoid arthritis.

Authors:  J A Milne; J R Anderson; R N MacSween; K Fraser; I Short; J Stevens; G B Shaw; H I Tankel
Journal:  Br Med J       Date:  1967-02-25

10.  Mefenamic acid and flufenamic acid compared with aspirin and phenylbutazone in rheumatoid arthritis.

Authors:  D E Barnardo; H L Currey; R M Mason; W R Fox; M Weatherall
Journal:  Br Med J       Date:  1966-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.